Abstract:Abstract Background: Brain metastases (BM) are the most common malignant tumors affecting the human central nervous system, more than 50% of BM are lung cancer. However, there is currently no universal and effective screening tool for lung cancer with BM. The study aimed to identify key genes of lung cancer with BM, achieving early and accurate diagnosis of lung cancer with BM and long-term monitoring of the therapeutic response. Methods: RNA-seq data and related clinical information were downloaded from the Gene Expression Omnibus (GEO) database. The weighted gene co-expression network (WGCNA) analysis was performed using WGCNA package and MEtuequois module was considered as the highest correlation. The Limma package of R was used to obtain differentially expressed genes (DEGs) between lung cancer with BM and healthy samples. The Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway enrichments of DEGs were analysed. LASSO and SVM were used to derive key genes for lung cancer with BM, and survival analysis was used to verify the correlation between the outcome and the key genes that we found. Key genes are annotated by GSEA, and CIBERSORT was used to calculate immune infiltration from samples. Results: 5 co-expression modules were detected, and ME turquois was most significantly associated with BM in lung cancer. These genes were mainly enriched in biological processes related to cell adhesion and immunity, and the main signaling pathways are significantly related to disease and cell adhesion. 4 BM-related key genes (AQP1, GSTA1, ROS1, TGFB1I1) were identified by LASSO regression analysis and SVM-RFE screening, they were demonstrated as the potential markers for lung cancer with BM. Immune cell infiltration revealed that they were negatively correlated with T cells regulatory, T cells CD8 and Mast cells activated. Overall survival correlation analysis confirmed that the expression of AQP1, GSTA1 and TGFB1I1 was negatively correlated with the prognosis of lung cancer patients, ROS1 was positively correlated with the prognosis of patients. Conclusions: AQP1, GSTA1, TGFB1I1 and ROS1 were identified as key genes of lung cancer with BM patients, which may regulate cancer progression by regulating immunity and have potential prognostic effects.

Identification and analysis of genes associated with lung adenocarcinoma by integrated bioinformatics methods

Identification of Key Genes and Evaluation of Clinical Outcomes in Lung Squamous Cell Carcinoma Using Integrated Bioinformatics Analysis

Interactive Verification Analysis of Multiple Sequencing Data for Identifying Potential Biomarker of Lung Adenocarcinoma

Identification of Stage-associated MicroRNAs in Lung Adenocarcinoma Based on Microarray Data

Identification of Hub Genes of Lung Adenocarcinoma Based on Weighted Gene Co-Expression Network in Chinese Population

Identification of Key Genes with Differential Correlations in Lung Adenocarcinoma

Identification of Genes Associated with Lung Adenocarcinoma Prognosis

Identification of potential key molecular biomarkers in lung adenocarcinoma by bioinformatics analysis

Analysis of prognostic model based on immunotherapy related genes in lung adenocarcinoma

Identification of potential core genes in lung cancer and therapeutic traditional Chinese medicine compounds using bioinformatics analysis

Identification of prognostic genes in lung adenocarcinoma immune microenvironment

Identification of Key Genes in Lung Adenocarcinoma and Establishment of Prognostic Mode

Weighted Gene Coexpression Network Analysis of Features That Control Cancer Stem Cells Reveals Prognostic Biomarkers in Lung Adenocarcinoma

Identification of tumor-suppressor genes in lung squamous cell carcinoma through integrated bioinformatics analyses

Machine learning and bioinformatics analysis of diagnostic biomarkers associated with the occurrence and development of lung adenocarcinoma

Weighted Gene Co-Expression Network Analysis and Treatment Strategies of Tumor Recurrence-Associated Hub Genes in Lung Adenocarcinoma

Identification of Key Genes Related to Lung Squamous Cell Carcinoma Using Bioinformatics Analysis

Identification of key candidate genes associated with prognosis of lung adenocarcinoma by integrated bioinformatical analysis

Identification of Susceptible Genes for Chronic Obstructive Pulmonary Disease with Lung Adenocarcinoma by Weighted Gene Co-Expression Network Analysis

Comprehensive analysis of lung adenocarcinoma: Unveiling differential gene expression, survival‐linked genes, subtype stratification, and immune landscape implications

Identification of Key Genes Related to Lung Cancer with Brain Metastasis through Weighted Gene Correlation Network Analysis